Caspari D
Universitäts-Nervenklinik--Psychiatrie und Psychotherapie, Homburg/Saar.
Eur Arch Psychiatry Clin Neurosci. 1999;249(1):45-9. doi: 10.1007/s004060050064.
A total of 39 schizophrenic patients with a history of current cannabis abuse at index admission was compared with a control group of schizophrenics without substance abuse matched for age, gender, and year of admission. At follow-up after 68.7+/-28.3 months, 27/ 39 cases and 26/39 controls could be investigated. 8/27 cases (30%) had continued cannabis abuse, 6/27 (22%) had become alcohol abusers. Only one patient of the control group had started abusing alcohol. Patients with previous cannabis abuse had significantly more rehospitalizations, tended to worse psychosocial functioning, and scored significantly higher on the psychopathological syndromes "thought disturbance" (BPRS) and "hostility" (AMDP). These results confirm the major impact of cannabis abuse on the long-term outcome of schizophrenic patients.
共有39名在首次入院时有当前大麻滥用史的精神分裂症患者与一组年龄、性别和入院年份相匹配的无物质滥用的精神分裂症对照组进行了比较。在68.7±28.3个月的随访中,39例中的27例和39例对照组中的26例可接受调查。27例患者中有8例(30%)持续滥用大麻,6例(22%)成为酒精滥用者。对照组中只有1名患者开始滥用酒精。既往有大麻滥用史的患者再次住院的次数明显更多,社会心理功能往往更差,在精神病理综合征“思维紊乱”(简明精神病评定量表)和“敌意”(精神症状评定量表)上的得分明显更高。这些结果证实了大麻滥用对精神分裂症患者长期预后的重大影响。